S-EPMC12724298 - Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy. - OmicsDI

Unknown

Dataset Information

Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy.

ABSTRACT:

SUBMITTER: Hu S

PROVIDER: S-EPMC12724298 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature